Cargando…

Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites

Although the robust antidepressant effects of the N-methyl-d-aspartate receptor (NMDAR) antagonist ketamine in patients with treatment-resistant depression are beyond doubt, the precise molecular and cellular mechanisms underlying its antidepressant effects remain unknown. NMDAR inhibition and the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chun, Yang, Jianjun, Luo, Ailin, Hashimoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838457/ https://www.ncbi.nlm.nih.gov/pubmed/31699965 http://dx.doi.org/10.1038/s41398-019-0624-1

Ejemplares similares

Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking
por: Altê, Glorister A., et al.
Publicado: (2023)

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
por: Hashimoto, Kenji
Publicado: (2019)

Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
por: Wohleb, Eric S., et al.
Publicado: (2017)

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
por: Xu, Songbai, et al.
Publicado: (2022)

Ketamine: A tale of two enantiomers
por: Jelen, Luke A, et al.
Publicado: (2020)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
por: Ho, Ming-Fen, et al.
Publicado: (2019)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
por: Zanos, Panos, et al.
Publicado: (2016)

Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
por: Yao, Wei, et al.
Publicado: (2021)

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
por: Wei, Yan, et al.
Publicado: (2021)

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
por: Yang, Bangkun, et al.
Publicado: (2016)

Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
por: Yao, Wei, et al.
Publicado: (2021)

Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
por: Zunszain, P A, et al.
Publicado: (2013)

A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
por: Hashimoto, Kenji
Publicado: (2012)

A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice
por: Burnside, Wesley M, et al.
Publicado: (2013)

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
por: Bonaventura, Jordi, et al.
Publicado: (2021)

Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure
por: Li, Su-Xia, et al.
Publicado: (2014)

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
por: Matveychuk, Dmitriy, et al.
Publicado: (2020)

Assessment of Ketamine and its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness
por: Zhu, Jackie, et al.
Publicado: (2020)

(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
por: Ago, Yukio, et al.
Publicado: (2019)

Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
por: Ficek, Joanna, et al.
Publicado: (2016)

Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
por: Zhang, Kai, et al.
Publicado: (2020)

Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
por: Yang, Chun, et al.
Publicado: (2017)

Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
por: Zhang, Kai, et al.
Publicado: (2018)

Antidepressant mechanism of ketamine: perspective from preclinical studies
por: Scheuing, Lisa, et al.
Publicado: (2015)

Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.
por: Chen, Guang, et al.
Publicado: (2022)

Ketamine: stimulating antidepressant treatment?
por: Malhi, Gin S., et al.
Publicado: (2016)

Immunoregulation and antidepressant effect of ketamine
por: Zhang, Nan, et al.
Publicado: (2021)

No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model
por: Chang, Lijia, et al.
Publicado: (2018)

Is (S)-norketamine an alternative antidepressant for esketamine?
por: Hashimoto, Kenji, et al.
Publicado: (2018)

Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions
por: Wegman-Points, Lauren, et al.
Publicado: (2020)

A Multiscale View of the Mechanisms Underlying Ketamine’s Antidepressant Effects: An Update on Neuronal Calcium Signaling
por: Kawatake-Kuno, Ayako, et al.
Publicado: (2021)

Author Correction: Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
por: Zhang, Kai, et al.
Publicado: (2018)

Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
por: Dong, Chao, et al.
Publicado: (2016)

5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
por: Zhang, Kai, et al.
Publicado: (2017)

Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
por: Zhang, Kai, et al.
Publicado: (2018)

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
por: Shirayama, Yukihiko, et al.
Publicado: (2017)

Enantioselective Behavior of Flumequine Enantiomers and Metabolites' Identification in Sediment
por: Xue, Moyong, et al.
Publicado: (2022)

Cellular and molecular mechanisms in the long-term action of antidepressants.
por: Racagni, Giorgio, et al.
Publicado: (2008)

The Ketamine Antidepressant Story: New Insights
por: Alshammari, Tahani K.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i7a26pb26jeiquc5390irkf8iv